Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Adenovirus associated viral vector serotype 4 containing the human RPE65 gene

EU orphan designation number: EU/3/07/484   
Active ingredient: Adenovirus associated viral vector serotype 4 containing the human RPE65 gene
Indication: Treatment of Leber's congenital amaurosis
Sponsor: Centre Hospitalier Universitaire de Nantes
5 allée de l'Île-Gloriette, F-44093 Nantes, CEDEX 1, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/10/2007 Centralised Orphan - Designation EMEA/OD/072/07 (2007)5241 of 22/10/2007